Search Results

You are looking at 1 - 10 of 99 items for :

  • "vancomycin" x
  • Medical and Health Sciences x
  • All content x
Clear All
Acta Microbiologica et Immunologica Hungarica
Authors: Máté Szász, Mária Hajdú, Natasa Pesti, Mónika Domahidy, Katalin Kristóf, ákos Zahár, Károly Nagy, and Dóra Szabó

.M., Composto, R.J., Freeman, T.A., Wickstrom, E., Ducheyne, P., Jungkind, D., Shapiro, I.M., Hickok, N.J.: The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic

Restricted access

53 65 Leclercq, R., Derlot, E., Duval, J., Courvalin, P.: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium . NEngl J Med 319 , 157

Restricted access

species most frequently isolated from clinical samples ( Maasjost et al., 2009 ) and cloacal samples of poultry ( Ünal et al., 2017; Aslantaş, 2019 ). Glycopeptides (such as vancomycin and teicoplanin) are effective antibiotics for the treatment of Gram

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: Sajith Vellappally, Darshan Devang Divakar, Abdulaziz Abdullah Al Kheraif, Ravikumar Ramakrishnaiah, Amer Alqahtani, M. H. N. Dalati, Sukumaran Anil, Aftab Ahmed Khan, and P. R. Harikrishna Varma

increased concern and a major pathogen of hospital-acquired infections [ 1, 2 ]. Vancomycin was considered to be the best alternative for the treatment of multidrug-resistant MRSA. However, there have been increasing reports of vancomycin-resistant S

Restricted access

Hryniewicz, W., Szczypa, K., Bronk, M., Samet, A., Hellmann, A., Trzcinski, K.: First report of vancomycin-resistant Enterococcus faecium isolated in Poland. Clin Microbiol Infect 5 , 503-505 (1999

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: Milica Jovanović, Branko Milošević, Tanja Tošić, Goran Stevanović, Vesna Mioljević, Nikola Inđić, Branko Velebit, and Marcus Zervos

References 1. Cetinkaya , Y. , Falk , P. , Mayhall , C.G. : Vancomycin-resistant enterococci . Clin Microbiol Rev 13 , 686 – 707 ( 2000

Restricted access

-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J. Appl. Microbiol. 89 , 478–485. Kruse H. Continuing high prevalence of VanA

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: Milica Jovanović, Branko Milošević, Olga Dulović, Mijomir Pelemiš, Goran Stevanović, Tanja Tošić, Branka Stošović, and M.J. Zervos

Linden, P.K., Miller, C.B.: Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen. Diagn Micr Infect Dis 33 , 113–120 (1999). Miller C

Restricted access
Orvosi Hetilap
Authors: Valentin Brodszky, László Gulácsi, Endre Ludwig, Gyula Prinz, János Banai, Péter Reményi, Bálint Strbák, Adrienne Kertész, Irén Kopcsóné Németh, Edit Zsoldiné Urbán, Petra Baji, and Márta Péntek

Cornely, O. A., Crook, D. W., Esposito, R., et al.: Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect. Dis., 2012, 12 , 281

Restricted access
Orvosi Hetilap
Authors: Marcell Szabó, Anna Bozó, Sándor Soós, Katalin Darvas, László Harsányi, and Ákos Csomós

), 421–433. 5 Leclercq, R., Derlot, E., Duval, J., et al.: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med., 1988

Open access